Printer Friendly

SCIMED ANNOUNCES INTRODUCTION OF HIGH-PERFORMANCE, NON-COMPLIANT PTCA BALLOON CATHETER AND ITS FIRST CORONARY GUIDE WIRE

SCIMED ANNOUNCES INTRODUCTION OF HIGH-PERFORMANCE, NON-COMPLIANT PTCA
 BALLOON CATHETER AND ITS FIRST CORONARY GUIDE WIRE
 MINNEAPOLIS, Nov. 13 /PRNewswire/ -- SCIMED Life Systems, Inc. (NASDAQ-NMS: SMLS) announced today that it has introduced NC Shadow(TM), a .014" wire compatible, non-compliant addition to its Shadow(TM) over- the-wire PTCA balloon catheter line, and EnTre(TM), SCIMED's first coronary guide wire, available in .014" and .018" sizes. FDA approval of these two products was announced by the company on Oct. 27, 1992. Both products will be displayed at the American Heart Association's conference to be held in New Orleans, Nov. 16 to 19.
 NC Shadow combines the strength and thin walls of TRIAD(TM), SCIMED's new patent-pending, non-compliant PET (polyethylene terephthalate) balloon material, with the thinnest distal shaft (2.7F) of any over-the-wire catheter currently on the market. The TRIAD balloon material was carefully designed to be of a lower molecular weight than that of competitors, with the intent of avoiding patent infringement problems. The shaft, a patented, tapered design, is constructed of SCIMED's high-performance, naturally lubricious Scilene(TM), providing the same performance characteristics for which SCIMED Shadow catheters are well known.
 EnTre combines the strengths of unibody core wire technology, pioneered by SCIMED, which reduces kinking and improves steerability, and a unique distal coating, called Protective Polymer Sleeve or P.P.S., which also improves its steerability characteristics. The shaft length is 190 cm, longer than other guide wires, which makes it easier to use with SCIMED's TRAPPER(TM) exchange device. EnTre is not equipped with a conventional exchange system, but is designed to be used with the TRAPPER when used with an over-the-wire catheter. It is also compatible with all rapid exchange catheters.
 Dale A. Spencer, president and chief executive officer, commented, "Balloon catheters represent the most critical working component of an angioplasty procedure in that it is the device element that actually dilates the obstructed segment or lesion. Physicians have a variety of balloon compliance needs, based on various clinical circumstances and physician preferences for different balloon catheter characteristics. It is strategically significant that SCIMED is the first and only company which has internally developed and now offers three different balloon materials designed to give physicians the ability to choose from one company the balloon material which best answers their particular needs in multiple clinical scenarios.
 "SCIMED's proprietary, predictably compliant POC-6 (polyolefin copolymer) balloon material is expected to remain SCIMED's largest selling balloon material due to its ability to provide accurate sizing to meet the clinical requirements for a wide range of patients, which we believe helps to reduce the number of catheters used per procedure and saves time and money. POC-8, also predictably compliant, which is the balloon material used on SCIMED's popular Skinny(TM) line of balloon catheters and which was recently introduced on the SC Shadow(TM) catheter, is designed for physicians who desire less balloon compliance, especially at higher dilatation pressures. The unique TRIAD balloon technology addresses the needs of physicians who require non-compliant balloon performance characteristics for the treatment of a growing population of patients with hard or unyielding lesions. NC Shadow will compete in the non-compliant PTCA balloon catheter segment, which we estimate comprises approximately 10 percent of the current worldwide PTCA balloon catheter market.
 "EnTre, SCIMED's first entry into the guide wire market, represents a new strategic opportunity for the company. The product is specifically designed to be used with rapid exchange catheters or SCIMED's TRAPPER exchange device in conjunction with over-the-wire catheters, which, when combined, represent approximately 40 percent of the total $100 million worldwide market for coronary guide wires.
 "We expect to invest at least 50 percent more in research and development this year than we did in fiscal 1992. Both of these new products are evidence of SCIMED's commitment to new product development and our goal of continuously improving and expanding our product lines."
 SCIMED Life Systems, Inc. develops, manufactures, and markets disposable medical devices, principally coronary and peripheral angioplasty catheters, for non-surgical treatment of cardiovascular disease. SCIMED's shares are traded on the NASDAQ National Market System under the symbol SMLS.
 -0- 11/13/92
 /CONTACT: Karen J. Kelsey, director, investor and public relations of SCIMED, 612-494-1329/
 (SMLS) CO: SCIMED Life Systems, Inc. ST: Minnesota IN: MTC SU: PDT


AL -- MN005 -- 0610 11/13/92 10:30 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 13, 1992
Words:718
Previous Article:MARION MERRELL DOW LAUNCHES NICOTINE PATCH AS A NONPRESCRIPTION AID IN THE UNITED KINGDOM
Next Article:FIRST WALT DISNEY WORLD EMPLOYEE, PHIL SMITH, RETIRING; BILL O'TOOLE NAMED SUCCESSOR AS SENIOR VP, ADMINISTRATION/SUPPORT
Topics:


Related Articles
SCIMED TO INTRODUCE THREE NEW PRODUCTS
SCIMED ANNOUNCES NEW PRODUCT
TWO NEW CORDIS ANGIOPLASTY CATHETERS GAIN U.S. MARKET RELEASE
SCHNEIDER BEGINS MARKETING PTCA OVER-THE-WIRE BALLOON CATHETER
FOUR CORDIS ANGIOPLASTY CATHETERS APPROVED FOR US MARKET RELEASE
SCIMED ANNOUNCES NEW PTCA GUIDE WIRE SYSTEM
SCHNEIDER BEGINS MARKETING BALLOON CATHETER 'FREEHAND'
CORDIS INTRODUCES NEW ANGIOPLASTY CATHETER LINE
SCHNEIDER LAUNCHES THREE NEW BALLOON CATHETERS
SCIMED DISPLAYS FIVE NEW DEVICES AT

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters